Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Hb Benedict

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 24, 2021
Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up studyCecilie Jacobsen, Robert Zivadinov, Kjell-Morten Myhr, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2017
Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE studyRalph Hb Benedict, Stanley Cohan, Sharon G Lynch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 8, 2020
Conscientiousness and deterioration in employment status in multiple sclerosis over 3 yearsMichael G Jaworski, Tom A Fuchs, Michael G Dwyer, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Repeated forms, testing intervals, and SDMT performance in a large multiple sclerosis datasetTom A Fuchs, John Gillies, Michael G Jaworski, et al.
Multiple Sclerosis and Related Disorders|April 21, 2023
Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis studyDejan Jakimovski, Diego Silva, Niels Bergsland, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2018
Longitudinal personality change associated with cognitive decline in multiple sclerosisShumita Roy, Allison Drake, Tom Fuchs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2018
Dalfampridine benefits ambulation but not cognition in multiple sclerosisNikhil Satchidanand, Allison Drake, A Smerbeck, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2019
Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosisTom A Fuchs, Curtis Wojcik, Gregory E Wilding, et al.
Neuroimage. Clinical|June 6, 2021
Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRITom A Fuchs, Michael G Dwyer, Dejan Jakimovski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2013
Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patientsRalph Hb Benedict, Hanneke E Hulst, Niels Bergsland, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 24, 2021
Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up studyCecilie Jacobsen, Robert Zivadinov, Kjell-Morten Myhr, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2017
Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE studyRalph Hb Benedict, Stanley Cohan, Sharon G Lynch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 8, 2020
Conscientiousness and deterioration in employment status in multiple sclerosis over 3 yearsMichael G Jaworski, Tom A Fuchs, Michael G Dwyer, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Repeated forms, testing intervals, and SDMT performance in a large multiple sclerosis datasetTom A Fuchs, John Gillies, Michael G Jaworski, et al.
Multiple Sclerosis and Related Disorders|April 21, 2023
Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis studyDejan Jakimovski, Diego Silva, Niels Bergsland, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2018
Longitudinal personality change associated with cognitive decline in multiple sclerosisShumita Roy, Allison Drake, Tom Fuchs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2018
Dalfampridine benefits ambulation but not cognition in multiple sclerosisNikhil Satchidanand, Allison Drake, A Smerbeck, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2019
Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosisTom A Fuchs, Curtis Wojcik, Gregory E Wilding, et al.
Neuroimage. Clinical|June 6, 2021
Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRITom A Fuchs, Michael G Dwyer, Dejan Jakimovski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2013
Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patientsRalph Hb Benedict, Hanneke E Hulst, Niels Bergsland, et al.
Pageof 7